Effects of a Multi-Ingredient Oral Supplement on Multiple Object Tracking, Reaction Time, and Reactive Agility.

What Was Tested

This randomized controlled trial looks at Copper (Supplement).

Therefore, the purpose of this study is to examine the effects of the 4D dietary supplement on cognition, reaction time, and reactive agility.

Repeated measures ANOVAs were used to evaluate YRA performance and change values for Dynavision RT, Dynavision score, and MOT speed with either 4D dietary supplement or placebo.

Who Took Part

PubMed indexes the participants as teenagers, young adults and adults, both men and women.

Seventeen healthy males (n = 8) and females (n = 9) between the ages of 18-40 years old (22.8 ± 2.9 years; 167.3 ± 9.6 cm; 65.4 ± 10.9 kg) participated in this double-blind, randomized crossover study.

Participants completed three baseline reaction time assessments on the Dynavision and one baseline multiple object tracking assessment on the Neurotracker.

How the Study Was Run

In design terms this was a randomized, double-blind, placebo-controlled and crossover study.

Random assignment meant chance, not the researchers, decided who got Copper (Supplement) and who got the comparison, which limits bias.

Neither the participants nor the staff measuring them knew who was on Copper (Supplement), so expectations could not easily colour the readings.

Some participants received a placebo instead of Copper (Supplement), giving a reference point.

In the crossover set-up each of the participants took both Copper (Supplement) and the comparison in turn, acting as their own control.

Following the rest period, participants completed an additional three reaction time assessments and one multiple object tracking (MOT) assessment, as well as 6-12 trials of the Y-reactive agility test.

What Was Measured

PubMed files the paper under topics including Caffeine, Reaction Time, Dietary Supplements and Rest.

Author keywords: cognition, multi-ingredient supplements and reactive agility.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Copper (Supplement).

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2022 (Journal of the International Society of Sports Nutrition), a journal based in United States.

More context: the Copper (Supplement) compound page, all human trials.